Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

DOI Full Paper Access

55

Citations

18

References

2021

Year

Anant Mohan, Pawan Tiwari, Tejas Menon Suri, Saurabh Mittal, Ankit Patel, Avinash Jain, Thirumurthy Velpandian, Ujjalkumar Subhash Das, Tarun Krishna Boppana, Ravindra Mohan Pandey,

Journal of Infection and Chemotherapy

VaccinationModerate Covid-19Covid-19 PandemicImmunologyAntiviral TherapyVirologyPlacebo-controlled TrialInfection ControlClinical Infectious DiseaseMedicineSingle-dose Oral IvermectinCovid-19

References

	Year	Citations

Page 1

Page 1